Males with positive biopsy (n=81) | Males with positive PDD (n=60) | Sensitivity | p-value* | |
---|---|---|---|---|
0-4 | 2 | 2 | 100% | |
4-10 | 39 | 28 | 71.8% | |
10-20 | 15 | 11 | 73.3% | |
20- | 25 | 19 | 76.0% | 0.25 |
Gleason score | ||||
6 | 24 | 15 | 62.5% | |
7 | 34 | 26 | 76.4% | |
8-10 | 23 | 19 | 82.6 | 0.11 |
Clinical stage | ||||
cT1 | 45 | 34 | 75.6% | |
cT2 | 32 | 22 | 68.8% | |
cT3 | 4 | 4 | 100% | |
cT4 | - | - | - | 0.87 |